The number of people who regularly attended needle and syringe programmes (NSP) in Wales in order to access safe equipment to inject drugs, reduced by more than a quarter in 2021-22, compared to 2019-20 (Public Health Wales)
Bibliography: All Publications
Opioid- and Stimulant-related Harms in Canada
Presented here are the most recent available data on overdoses and deaths involving opioids and/or stimulants from January 2016 to September 2022 in Canada, where available (Government of Canada)
EU Drugs Agency: Commission welcomes political agreement on new fully-fledged Agency
The Commission welcomes today’s political agreement between the European Parliament and the Council on a stronger mandate which establishes a new EU Drugs Agency. The new Agency builds on the achievements of the European Monitoring Centre for Drugs and Drug Addiction
Can buprenorphine-equipped ambulances help link overdose survivors to addiction treatment?
This study examined preliminary outcomes of an innovative model where overdose survivors receive ambulance-based buprenorphine and addiction treatment linkage (Recovery Research Institute)
Global reviews of injecting drug use highlight inadequate coverage of interventions for people who use drugs
Lead researcher, NDARC’s Scientia Professor Louisa Degenhardt said the landscape has changed since the last review, including increased support for research across multiple low-income and middle-income countries, shifts in patterns of drug use, the development of targets for reductions in HIV and viral hepatitis infection, and the inclusion of drug dependence treatment as one of the United Nations Sustainable Development Goals (NDARC)
Searching the grey literature to access research on illicit drug use, blood borne virus, and coverage of interventions among people who are incarcerated
This technical report outlines websites associated with various databases and organisations that could provide grey literature resources related to illicit drug use, blood borne virus, and coverage of interventions amongst people who are incarcerated (NDARC)
Wastewater samples from over 100 European cities reveal latest drug-taking trends
The latest findings from the largest European project in the science of wastewater analysis are released today in Wastewater analysis and drugs — a European multi-city study (EMCDDA)
Shooting Up: infections among people who inject drugs in the UK
This report describes the extent of infections and injecting-related harms among people who inject drugs (PWID) in the United Kingdom (UK Health Security Agency)
Global Report on Cocaine 2023
UNODC
Interim monitoring report on statutory funded residential rehabilitation placements
Placements approved by Alcohol and Drug Partnerships between 1 April 2021 and 31 December 2022 (Public Health Scotland)
The death penalty for drug offences: global overview 2022
This report, our twelfth on the subject, continues our work of providing regular updates on legislative, policy and practical developments related to the use of capital punishment for drug offences, a practice which is a clear violation of international standards (Harm Reduction International)
Substance misuse treatment in secure settings: 2021 to 2022
Statistics for alcohol and drug misuse treatment in prisons and other secure settings from the National Drug Treatment Monitoring System (NDTMS)
Report 18 of the National Wastewater Drug Monitoring Program
Report 18 of the National Wastewater Drug Monitoring Program covered sampling in August and October 2022. In August, 58 wastewater sites were monitored nationally, covering approximately 57% of the Australian population Download report
Global launch of the Annual Report 2022
INCB
Peer naloxone supply project
An evaluation of three pilot areas,(SDF)
Women and drugs: health and social responses
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview of the most important aspects to consider when planning or delivering health and social responses for women who use drugs, and reviews the availability and effectiveness of the responses (EMCDDA)
Drug and Alcohol Treatment and Recovery Workforce Programme
This programme aims to transform the lives of those affected by drug and alcohol misuse by improving the quality and capacity of the drug and alcohol treatment and recovery workforce (NHS Health Education England)
Publication of ACMD’s review on nitrous oxide
The Advisory Council on the Misuse of Drugs (ACMD) has today (6 March 2023) published an updated harms assessment of nitrous oxide
Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms
Framework for action for integrated care boards (ICBs) and primary care (NHS England)
Monitoring Data Report 2022
Together with more than one hundred organizations and individuals from thirty-four European countries, C-EHRN set up for itself the task to provide an in-depth look at Harm Reduction in Europe – download report
Taking the initiative: how England is eliminating hepatitis C
This report explores the development of the programme, how several of the key initiatives have worked and developed over time, and next steps in the programme (HCV Action)
Youth Risk Behavior Survey Data Summary & Trends Report: 2011–2021
Provides the most recent surveillance data, as well as 10-year trends, on health behaviours and experiences among high school students in the United States (U.S.) related to adolescent health and well-being (CDC)
New EMCDDA work programme prepares agency for significant changes ahead
the latest EMCDDA work programme, which outlines our activities for 2023–2025
How England is eliminating hepatitis C
This report explores the development of the programme, how several of the key initiatives have worked and developed over time, and next steps in the programme (HCV Action)
Synthetic opioids will be banned as government acts to stop drug deaths
Eleven more lethal substances to be made Class A drugs, following a recommendation by the Advisory Council on the Misuse of Drugs (Home Office)
Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists
From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions (Australian Government)
Hepatitis C in the UK 2023
Working to eliminate hepatitis C as a public health threat (Health Security Agency)
Substance misuse treatment for young people: statistics 2021 to 2022
Alcohol and drug treatment data for young people under 18, from the National Drug Treatment Monitoring System (Office for Health Improvement and Disparities)
Impact of the California Harm Reduction Initiative
RTI’s National Survey of Syringe Service Programs (SSPs) showed that California’s investment in harm reduction yielded high levels of life-saving interventions in its three years of existence
Naloxone knowledge among a sample of people that regularly consume illicit stimulants in Australia, 2022
This bulletin investigates naloxone knowledge among a sample of people that regularly use illicit stimulant drugs recruited from capital cities in Australia in 2022 (NDARC)
Preventing burnout and improving resilience in hospital-based addiction medicine professionals
This study asked 26 clinicians working on multidisciplinary addiction consultation teams to identify factors connected with burnout and resilience (Recovery Research Institute)
Rapid Action Drug Alerts and Response (RADAR) quarterly report
The Drugs Team at Public Health Scotland (PHS) has compiled this report of drug-related indicators in order to inform action to prevent drug harms and deaths
Opioids Prescribed to Adults at Discharge From Emergency Departments: United States, 2017–2020
Opioids may be an effective treatment for chronic and acute pain when properly used (1). However, receiving an opioid prescription in the emergency department (ED) has been identified as a potential risk factor for long-term use (CDCX)
Substance misuse treatment for adults: statistics 2021 to 2022
Statistics on alcohol and drug misuse treatment for adults from the National Drug Treatment Monitoring System (NDTMS)
Party Panel: developing theory- and evidence-based health promotion in nightlife settings
This paper describes the development and results of a web survey, named the Party Panel, that addresses emerging risks in nightlife settings (EMCDDA)
Drug Deaths Taskforce response: cross government approach
Cross government response to the Drug Deaths Taskforce report, Changing Lives. It contains a cross government action plan, response to Taskforce recommendations and a stigma action plan (Scottish Government)
High Intensity Drug Trafficking Areas Program 2022 Report to Congress
This document presents a national overview of the HIDTA Program, including an evaluation of each HIDTA, and addresses the following three Congressional reporting requirements in one cohesive and coordinated report (White House)
SAMHSA Announces National Survey on Drug Use and Health (NSDUH) Results Detailing Mental Illness and Substance Use Levels in 2021
The 2021 NSDUH national report includes selected estimates by race, ethnicity, and age group. It is the most comprehensive report on substance use and mental health indicators that SAMHSA has released to date
Drug Abuse Warning Network: Findings from Drug-Related Emergency Department Visits, 2021
An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (4) the identification of drugs new to DAWN’s Drug Reference Vocabulary (SAMHSA)
Joint Committee on Justice has published its Report on an examination of the present approach to sanctions for possession of certain amounts of drugs for personal use
The Joint Committee on Justice has published its Report on an examination of the present approach to sanctions for possession of certain amounts of drugs for personal use in which it makes a series of recommendations on the issue (Houses of the Oireachtas, Ireland)
- 1
- 2
- 3
- …
- 49
- Next Page »
